The genome-wide polygenic score was validated within 119,951 participants of the UK Biobank Phase 1 validation dataset, and subsequently tested in the remaining 288,016 participants. Avoidance of sample overlap between the validation and testing datasets prevents test statistic inflation (Vilhjalmsson et al., 2015).
